Due Diligence &

Partnership

Due Diligence

The pharmaceutical industry is a fast-changing environment and the due diligence (DD) process is of equally high financial importance for seller (out-licensing) and buyer (in-licensing). With consultants experienced on both sides, we can assist you in the evaluation of a potential opportunity as well as in the preparation of a comprehensive package for the successful sale of your technology or project

Due Diligence Services for In-Licensing

Target evaluation
Preliminary DD evaluation (identification of early flags)
Deep-fact finding in eRoom
Formal face-to-face DD for early projects or clinical candidates
Identification of key safety issues and risk assessment
Assessment of regulatory dossier and evaluation of current and planned regulatory strategies
Evaluation of CMC information to determine current status of manufacturing feasibility and future development needs

Due Diligence Services for Out-Licensing

Identification of potential buyers
Organization of DD meetings
Preparation of a due diligence package
Identification of key missing data
Preparation of DD presentations
Evaluation of current regulatory dossier and gap analysis to assess regulatory hurdles which may impact project worth

Development Partnership

Non-Clinical Study Monitoring

CRO (Europe, North America, Asia) assessment, pre-selection, justified choice, audit and monitoring.
Study plan implementation, study follow-up, audits.
Report assessment, comments, correction and finalization.